The compound has not been subjected to the demanding clinical screening expected for approval by regulatory bodies including the FDA, which suggests its protection and effectiveness in treating professional medical ailments continue to be unproven.Nociceptive Pathways: Investigate indicates that conolidine could possibly have an affect on nocicepti